A Major Step for Georgia’s Medical Cannabis Program

On July 1st, Senate Bill 220, the “Putting Georgia’s Patients First Act,” became law, making Georgia the 41st medical cannabis state. 

I personally advocated for this bill during the legislative session, and what ultimately made it bipartisan was the compelling testimony of patients emphasizing the healing aspects of marijuana. Nothing proved more powerful than the testimony of patients who use cannabis to manage chronic pain. Hearing them describe, in their own words, the relief it brought where other treatments had failed moved legislators on both sides of the aisle, which was reflected in the overwhelming support from both chambers.

The new law substantially expands Georgia’s medical marijuana access program. SB 220 finally retires the misleading “low THC oil” label, replacing it with “medical cannabis” and scrapping the restrictive percentage language that left many patients underserved. In its place is a sensible 12,000 milligram THC possession limit. Further, those aged 21 and older may now vaporize their medicine, and the qualifying-condition list has expanded to include lupus, inflammatory bowel disease, and others. The law also strips outdated “severe” and “end-stage” requirements for certain conditions, further expanding access to more patients that can benefit from medical cannabis products. 

Georgia’s most compelling achievement, however, may be its dispensing system. In October 2023, Georgia became the first state in the nation to authorize the dispensing of medical cannabis directly through licensed independent pharmacies. This particular distribution model has no equivalent anywhere else in the country. Whereas most medical cannabis states confine sales to a limited number of standalone dispensaries, Georgia fused cannabis distribution onto the existing pharmacy infrastructure.

In a large state of roughly 11 million people, a handful of vertically integrated dispensaries could never realistically reach the full population.The innovative pharmacy network shatters this ceiling. With nearly 120 independent pharmacy partners now actively distributing medical cannabis products, it has been estimated that close to 90 percent of Georgia’s population are within a 30-minute drive of access. 

While we commend this progress, we also recognize many Georgians are still a long way from justice. Two-thirds of Georgians support legalizing marijuana, yet thousands are still arrested annually for simple possession, with Black Georgians arrested at three times the rate of white residents despite similar usage patterns. Smoking cannabis remains banned, even for qualified patients, and THC edibles are still restricted. Employment protections are non-existent and rural patients still face real barriers to access. 

The enactment of SB 220 is a significant step forward, but it still falls short of what most Georgians want and deserve. However, as a battleground state with turbulent politics, legalization may not be an upcoming priority for state lawmakers, even despite majority public support. 

Ultimately, the pace of reform in Georgia rests with the voters. So long as Georgians keep voting for legislators who are out of touch with the public on cannabis policy, they will keep getting cannabis laws contrary to their own views. It’s time to hold lawmakers accountable by making marijuana law reform a decisive factor in how we vote.

Related